(Q63337353)
Statements
An Open-Label, Long-Term, Follow-Up Study of Subcutaneous ELND002 in Patients With Relapsing Forms of Multiple Sclerosis (English)
0 references
December 2010
0 references
December 2012
0 references
12
0 references
18 year
0 references
65 year
0 references